CDC recommends IgM antibody detection in patients who have IgM antibodies to dengue detected in their serum sample and had either a negative RT–PCR result in the acute phase sample or did not submit an acute phase sample; these are classified as having a recent probable dengue infection [35]. This evidence concerns the gene CD40LG and dengue disease.